60 F
New York
Friday, May 7, 2021

Lannett Inc. [NYSE: LCI] Introduces FDA Approved Levothyroxine Tablets

Must read

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Lannett Company Inc. [NYSE: LCI] has announced the launch of Cediprof Inc.’s FDA approved Levothyroxine Sodium Tablets USP. The company has earlier inked the temporary exclusive supply and distribution agreement for Levothyroxine with Cediprof Inc.

Previously, Lannett has disclosed that it is anticipating to start the distribution of Levothyroxine Tablets in the US on August 3. Today the Lannett Inc. has introduced the Levothroxyine Tablet which is FDA approved.

Lannett Company, Inc.’s shares soared 1.07% and up +0.06 during the trading of Monday. It has opened at $6.00 and has a closing price of $6.01. Lannett has a day low range of $5.95 and a high range of $6.02. It had a trading volume of 32.63K and an average volume of 723.85K.

In the past 52-weeks of trading, Lannett’s shares have fluctuated between the low of $4.89 and a high of $15.52. It has moved up 21.68% from its 52-weeks low and moved down -61.66% from its 52-weeks high.

If we look at its profitability, its return on assets (ROA) is -2.70%, return on investment (ROI) is -17.70% and return on equity (ROE) is -9.70%. Continuing to look at its liquidity, its quick ratio is 1.40 and current ratio is 2.00. While the company’s debt to equity ratio is 2.24.

Lannett Inc. has reported the sales of 541.70 million and has a market capitalization of 248.17 million. Its Gross Margin is 32.30%, Profit Margin is -5.80% and an Operating Margin is 5.80%.

Levothyroxine is the most prescribed drug in the US as it is an important medication for the ones with thyroid deficiency. Cediprof’s previous distribution partner disagreed with the new partner and challenge the termination notice it has received earlier.

But Judges in two courts rejected a request for a temporary restraining order from the previous distribution partner, which prohibit the Cediprof to end the previous agreement and transfer the distribution rights to Lannett. Now the court order removed the hurdle for the distribution of a product in the US.

More articles

Latest article

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...

R1 RCM [NASDAQ: RCM] Announces Acquisition of VisitPay

R1 RCM Inc. disclosed Tuesday that it has decided to purchase VisitPay. The firm has inked an agreement to buy VisitPay for nearly...

Binance Coin Makes History as its Market Cap Reach $100 Billion

The market capitalization of Binance set new records as the exchange token of Binance and the native asset of Binance Smart Chain (BSC) touched...

Precipio [NASDAQ: PRPO] Roll Out Rapid COVID-19 Antibody test on Amazon Platform

Shares of Precipio, Inc. skyrocketed 40.35% during the trading session of Monday. The strong performance of the firm has highlighted the positive sentiments...

TechX Ink Deal to Buy Fiat-to-Crypto Merchant Services Gateway XPort Digital

TechX Technologies Inc disclosed Monday that it has bought fiat-to-crypto merchant services gateway XPort digital. The firm has bought a 100% stake in XPort...

Lockheed [NYSE: LMT] Present F-35 Best and Final Offer to Finnish Government

Lockheed Martin Corporation disclosed that it has presented F-35 best and final offer (BAFO) on April 29, 2021, to the Finnish government. It...

Clene [NASDAQ: CLNN] Gets Two Patent Notice of Allowances

Clene Inc. disclosed that Clene Nanomedicine, Inc. U.S. Patent and Trademark Office has provided Notices of Allowance for two significant patent applications. Clene...